Sana Biotechnology reported net income of -$63.70M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 182.91M | 184.93M | 186.63M | 188.43M | 189.90M | 191.02M | 191.41M | 196.88M | 197.06M | 197.86M | 221.29M | 222.21M | 223.11M | 223.92M | 225.46M | 230.51M | 262.26M | 266.73M | 269.82M | 299.31M | ||||||
| Operating items | ||||||||||||||||||||||||||
| Research & DevelopmentR&D | 53.24M | 108.50M | 72.69M | 72.54M | 76.73M | 63.92M | 67.17M | 73.04M | 65.61M | 7.00M | 56.45M | 60.87M | 53.21M | 1.90M | 37.19M | 29.76M | 30.11M | 34.92M | 28.72M | 30.73M | ||||||
| Selling, General & AdministrativeSG&A | 13.43M | 12.68M | 14.43M | 18.29M | 15.51M | 23.32M | 16.77M | 16.57M | 19.18M | 20.78M | 16.27M | 16.44M | 14.05M | 17.28M | 11.48M | 10.34M | 10.29M | 12.19M | 11.46M | 10.78M | ||||||
| Other Operating ExpensesOther Opex | 16.75M | -9.90M | -55.44M | -17.93M | -6.06M | -5.45M | 0.12M | 26.68M | -82.61M | 62.84M | 38.01M | -27.94M | -5.50M | 31.69M | 1.96M | 54.87M | 3.12M | 14.09M | 8.43M | 23.91M | ||||||
| Operating ExpensesOpex | 83.43M | 111.28M | 31.68M | 72.90M | 86.19M | 81.79M | 84.05M | 116.29M | 2.18M | 90.62M | 110.72M | 49.37M | 61.76M | 50.87M | 50.63M | 94.97M | 43.52M | 61.20M | 48.61M | 65.42M | ||||||
| Operating IncomeOp. Inc | -83.43M | -111.28M | -31.68M | -72.90M | -86.19M | -81.79M | -84.05M | -116.29M | -2.18M | -90.62M | -110.72M | -49.37M | -61.76M | -50.87M | -50.63M | -94.97M | -43.52M | -61.20M | -48.61M | -65.42M | ||||||
| EBIT | -83.43M | -111.28M | -31.68M | -72.90M | -86.19M | -81.79M | -84.05M | -116.29M | -2.18M | -90.62M | -110.72M | -49.37M | -61.76M | -50.87M | -50.63M | -94.97M | -43.52M | -61.20M | -48.61M | -65.42M | ||||||
| Non-operating items | ||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.16M | -1.80M | -3.81M | -1.18M | 1.17M | 8.81M | 2.19M | 2.37M | 2.86M | 2.73M | 3.03M | 3.20M | 2.58M | 1.66M | 0.99M | 0.58M | 1.00M | 1.28M | 0.95M | 1.13M | ||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.01M | 0.28M | -0.10M | -0.20M | -0.11M | -0.27M | -0.05M | -0.08M | 0.30M | -0.22M | 0.21M | -4.12M | -0.74M | 0.14M | 0.25M | 0.60M | 0.36M | 1.10M | 0.45M | 0.66M | ||||||
| Net income details | ||||||||||||||||||||||||||
| EBT | -83.27M | -113.08M | -35.49M | -74.08M | -85.01M | -72.98M | -81.86M | -113.92M | 0.68M | -87.89M | -107.69M | -46.17M | -59.18M | -49.21M | -49.64M | -94.40M | -42.51M | -59.92M | -47.66M | -64.29M | ||||||
| Profit After TaxPAT | -83.36M | -112.02M | -31.45M | -72.47M | -85.19M | -78.36M | -82.12M | -114.00M | 1.65M | -88.12M | -107.47M | -50.29M | -59.92M | -49.07M | -49.39M | -93.80M | -42.15M | -58.83M | -47.21M | -63.70M | ||||||
| Income from Continuing OperationsIncome (Continuing) | -83.27M | -113.08M | -35.49M | -74.08M | -85.01M | -72.98M | -81.86M | -113.92M | 0.68M | -87.89M | -107.69M | -46.17M | -59.18M | -49.21M | -49.64M | -94.40M | -42.51M | -59.92M | -47.66M | -64.29M | ||||||
| Consolidated Net IncomeConsol Net Inc. | -83.27M | -113.08M | -35.49M | -74.08M | -85.01M | -72.98M | -81.86M | -113.92M | 0.68M | -87.89M | -107.69M | -46.17M | -59.18M | -49.21M | -49.64M | -94.40M | -42.51M | -59.92M | -47.66M | -64.29M | ||||||
| Income towards Parent CompanyParent Net Inc | -83.27M | -113.08M | -35.49M | -74.08M | -85.01M | -72.98M | -81.86M | -113.92M | 0.68M | -87.89M | -107.69M | -46.17M | -59.18M | -49.21M | -49.64M | -94.40M | -42.51M | -59.92M | -47.66M | -64.29M | ||||||
| Net Income towards Common StockholdersNet Income | -83.27M | -113.08M | -35.49M | -74.08M | -85.12M | -72.98M | -81.86M | -113.92M | 0.98M | -87.89M | -107.69M | -46.17M | -59.92M | -49.21M | -49.64M | -94.40M | -42.51M | -59.92M | -47.66M | -64.29M | ||||||
| Additional items | ||||||||||||||||||||||||||
| EPS (Basic) | -0.46 | -0.68 | -0.19 | -0.39 | -0.45 | -0.39 | -0.43 | -0.59 | 0.00 | -0.45 | -0.50 | -0.20 | -0.25 | -0.21 | -0.21 | -0.40 | -0.16 | -0.24 | -0.17 | -0.22 | ||||||
| EPS (Diluted) | -0.46 | -0.68 | -0.19 | -0.39 | -0.45 | -0.39 | -0.43 | -0.59 | 0.00 | -0.45 | -0.50 | -0.20 | -0.25 | -0.21 | -0.21 | -0.40 | -0.16 | -0.24 | -0.17 | -0.22 | ||||||
| Shares Outstanding | 181.83M | 166.43M | 185.96M | 187.63M | 189.30M | 188.34M | 191.23M | 192.54M | 196.98M | 194.54M | 217.29M | 234.44M | 235.41M | 230.89M | 237.58M | 238.41M | 260.49M | 253.23M | 276.86M | 295.67M | ||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 181.83M | 166.43M | 185.96M | 187.63M | 189.30M | 188.34M | 191.23M | 192.54M | 200.47M | 194.54M | 217.29M | 234.44M | 235.41M | 230.89M | 237.58M | 238.41M | 260.49M | 253.23M | 276.86M | 295.67M | ||||||
| EBITDA | -83.43M | -111.28M | -31.68M | -72.90M | -86.19M | -81.79M | -84.05M | -116.29M | -2.18M | -90.62M | -110.72M | -49.37M | -61.76M | -50.87M | -50.63M | -94.97M | -43.52M | -61.20M | -48.61M | -65.42M |